Irbesartan Tablet
Product Images NDC 43547-374

7 FDA label images from Solco Healthcare U.s., Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 43547-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare U.s., Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spl Image1 Structure)

Structure (Spl Image1 Structure)
Chemical structure of Irbesartan depicted as a molecular diagram showing its ring systems and functional groups.*
FDA Label Image

Figure 1 (Spl Image2 Figure1)

Figure 1 (Spl Image2 Figure1)
A line graph depicting the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis. Data points illustrate a trend of increasing reduction with higher doses, flattening at higher dose levels in an integrated analysis.*
FDA Label Image

Figure 2 (89925c3e C144 42fa 93f2 Cece97e4cda3 00)

Figure 2 (89925c3e C144 42fa 93f2 Cece97e4cda3 00)
A line graph titled 'Figure 2' depicting the placebo-subtracted reduction in trough SeDBP (systolic blood pressure) as a function of Irbesartan dose in mg/day. The x-axis represents the Irbesartan dose ranging from 0 to 900 mg/day, and the y-axis shows the reduction in mmHg from approximately -2 to 8. Data points are scattered and connected by a curve indicating increasing effect with higher doses.*
FDA Label Image

Figure 3 (Spl Image4 Figure3)

Figure 3 (Spl Image4 Figure3)
A cumulative event rate line graph illustrating comparison among Irbesartan, Amlodipine, and Placebo over months of follow-up. The graph shows percentage event rates on the y-axis and time in months on the x-axis, with distinct lines for each treatment group, highlighting relative risks and P-values between Irbesartan and Placebo, and Irbesartan and Amlodipine.*
FDA Label Image

75mg (Spl Image5 Irbesartan 75mg)

75mg (Spl Image5 Irbesartan 75mg)
Label for Irbesartan Tablets, USP 75 mg oral tablets. The label shows a count of 30 tablets and indicates prescription use only. It is distributed by Solco Healthcare US, LLC and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. Storage instructions and dosage information references are provided.*
FDA Label Image

150mg (Spl Image6 Irbesartan 150mg)

150mg (Spl Image6 Irbesartan 150mg)
Irbesartan Tablets USP 150 mg oral tablets packaging label showing a quantity of 30 tablets. The label includes storage instructions, manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd, and distributor Solco Healthcare US, LLC. The NDC 43547-375-03 and an Rx only designation are present.*
FDA Label Image

300mg (Spl Image7 Irbesartan 300mg)

300mg (Spl Image7 Irbesartan 300mg)
Label for Irbesartan Tablets, USP 300 mg oral tablets. The box contains 30 tablets. The label shows the product name and strength prominently, with a blue and purple color scheme. It includes storage instructions and manufacturer information for Zhejiang Huahai Pharmaceutical Co., Ltd., with distribution by Solco Healthcare U.S., LLC. The NDC number 43547-376-03 and Rx only designation are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.